CVRx is a private company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. The Barostim neo™ uses CVRx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. The Barostim neo can be adjusted to meet each patient’s individual therapy needs.
For Information on the Hypertension Pivotal Trial go to www.BloodPressureTrial.com
For information on the HOPE4HF Trial go to www.HeartFailureTrial.com